| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.2 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.2 |